Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

HPV jab effective against most cervical cancer strains

  • Comment

A jab to to protect teenage girls from the human papillomavirus (HPV) could save more lives that previously estimated, research has suggested.

A Health Protection Agency (HPA) review of the ongoing vaccination programme found the scheme could prevent as many as 77% of cervical cancer cases.

While the injection was designed to guard against strands 16 and 18 of the virus, experts now believe it also offers cross protection against a number of other varieties.

Scientists say the results mean the number of cases of cervical cancer across the UK could fall from almost 3,000 at the moment to fewer than 700 a year.

HPA epidemiologist Kate Soldan said: “We’ve found that, if vaccine uptake is good, the HPV vaccine should prevent the majority of cases of cervical cancer in this country.

“Because the vaccine is given to teenage girls and cervical cancer affects adult women, it will be some years before we see the actual impact of immunisation, but we do expect to start seeing these effects in coming years, as vaccinated girls become adults.”

Click here to see the article in the British Journal of Cancer.


  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs